Dr. Reddy's Recommends Rs. 8 Final Dividend, Sets AGM for July 23
Summary
Dr. Reddy's Laboratories announced its 42nd Annual General Meeting for July 23, 2026, and recommended a final dividend of Rs. 8 per equity share for FY26, with a record date of July 10, 2026.
Key Events
-
Final Dividend Recommendation
The Board recommended a final dividend of Rs. 8 per equity share (face value Rs. 1) for the financial year ended March 31, 2026.
-
Annual General Meeting (AGM)
The 42nd AGM is scheduled for Thursday, July 23, 2026, to be held via video conference.
-
Dividend Record Date
Friday, July 10, 2026, has been set as the record date for determining shareholders' entitlement to the final dividend.
-
Dividend Payment Date
If approved at the AGM, the dividend will be paid on or before July 30, 2026.
Analysis
The company's recommendation of a substantial Rs. 8 per share final dividend for FY26, representing a significant yield based on current market prices, signals strong financial performance and a commitment to shareholder returns. This dividend, if approved at the upcoming AGM, will be paid by July 30, 2026. Shareholders should note the July 10 record date and review the detailed tax deduction at source (TDS) information to ensure their details are updated by June 30 to avoid higher withholding taxes.
At the time of this filing, RDY was trading at $13.41 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.2B. The 52-week trading range was $12.19 to $15.71. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.